- Home
- REE vs CRIS Comparison
REE vs CRIS Comparison
Compare REE & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- CRIS
- Stock Information
- Founded
- REE 2011
- CRIS 2000
- Country
- REE Israel
- CRIS United States
- Employees
- REE N/A
- CRIS N/A
- Industry
- REE Auto Manufacturing
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REE Consumer Discretionary
- CRIS Health Care
- Exchange
- REE Nasdaq
- CRIS Nasdaq
- Market Cap
- REE 22.4M
- CRIS 22.9M
- IPO Year
- REE N/A
- CRIS 2000
- Fundamental
- Price
- REE $1.21
- CRIS $1.61
- Analyst Decision
- REE Strong Buy
- CRIS Strong Buy
- Analyst Count
- REE 2
- CRIS 2
- Target Price
- REE $11.75
- CRIS $16.50
- AVG Volume (30 Days)
- REE 1.1M
- CRIS 72.1K
- Earning Date
- REE 12-19-2025
- CRIS 11-13-2025
- Dividend Yield
- REE N/A
- CRIS N/A
- EPS Growth
- REE N/A
- CRIS N/A
- EPS
- REE N/A
- CRIS N/A
- Revenue
- REE $183,000.00
- CRIS $11,405,000.00
- Revenue This Year
- REE $327.73
- CRIS $2.72
- Revenue Next Year
- REE $36,888.82
- CRIS $8.27
- P/E Ratio
- REE N/A
- CRIS N/A
- Revenue Growth
- REE N/A
- CRIS 12.24
- 52 Week Low
- REE $0.53
- CRIS $1.02
- 52 Week High
- REE $11.72
- CRIS $5.27
- Technical
- Relative Strength Index (RSI)
- REE 63.27
- CRIS 50.58
- Support Level
- REE $1.14
- CRIS $1.49
- Resistance Level
- REE $1.41
- CRIS $1.63
- Average True Range (ATR)
- REE 0.18
- CRIS 0.10
- MACD
- REE 0.02
- CRIS 0.01
- Stochastic Oscillator
- REE 42.82
- CRIS 68.87
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.